b
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Product introduction:
Apremilast is an oral selective phosphodiesterase 4 (PDE4) inhibitor developed by celgene company of the United States. The trade name is otezla. It is the first and only PDE4 inhibitor approved by FDA for the treatment of plaque psoriasis. It is used for the treatment of adult patients with moderate to severe plaque psoriasis suitable for phototherapy and systemic therapy.
CAS：608141-41-9
Molecular formula: C22H24N2O7S
Molecular weight: 460.5
Structural type: 
Product purpose:
It is suitable for adult patients with active psoriatic arthritis.
Manufacturing
